Comparison of Two Pretransplant Predictive Models and a Flexible HCT-CI Using Different Cut off Points to Determine Low-, Intermediate-, and High-Risk Groups: The Flexible HCT-CI Is the Best Predictor of NRM and OS in a Population of Patients Undergoing allo-RIC

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 3, 2010, Pages 413-420

  Barba, Pere ^a   Piñana, Jose Luis ^a   Martino, Rodrigo ^a   Valcárcel, David ^a   Amorós, Alex ^b   Sureda, Anna ^a   Briones, Javier ^a   Delgado, Julio ^a   Brunet, Salut ^a   Sierra, Jorge ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Fundacion Avedis Donabedian   (Spain)

Author keywords

Allo RIC; Comorbidity index; HCT CI; Mortality; Reduced intensity conditioning stem cell transplantation

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; BUSULFAN; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; FLUDARABINE; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER MORTALITY; CHARLSON COMORBIDITY INDEX; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL PRACTICE; CLINICAL RESEARCH; COMORBIDITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FOLLICULAR LYMPHOMA; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL TRANSPLANTATION COMORBIDITY INDEX; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRETRANSPLANTATION ASSESSMENT OF MORTALITY MODEL; REDUCED INTENSITY CONDITIONING; RISK ASSESSMENT; SCORING SYSTEM; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; COMMUNICABLE DISEASES; COMORBIDITY; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG DISEASES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 75749127470     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.11.008     Document Type: Article

References (21)

1. Gratwohl A., Hermans J., Goldman J.M., et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 352 (1998) 1087-1092
2. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
3. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106 (2005) 2912-2919
4. Parimon T., Au D.H., Martin P.J., and Chien J.W. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med 144 (2006) 407-414
5. Sorror M.L., Giralt S., Sandmaier B.M., et al. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood 110 (2007) 4606-4613
6. Sorror M.L., Sandmaier B.M., Storer B.E., et al. Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. J Clin Oncol 25 (2007) 4246-4254
7. Farina L., Bruno B., Patriarca F., et al. The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation. Leukemia 23 (2009) 1131-1138
8. Pollack S.M., Steinberg S.M., Odom J., Dean R.M., Fowler D.H., and Bishop M.R. Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 15 (2009) 223-230
9. Majhail N.S., Brunstein C.G., McAvoy S., et al. Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants. Biol Blood Marrow Transplant 14 (2008) 985-992
10. Wildes T.M., Augustin K.M., Sempek D., et al. Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma. Biol Blood Marrow Transplant 14 (2008) 840-846
11. Labonté L., Iqbal T., Zaidi M.A., et al. Utility of comorbidity assessment in predicting transplantation-related toxicity following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 14 (2008) 1039-1044
12. Guilfoyle R., Demers A., Bredeson C., et al. Performance status, but not the hematopoietic cell transplantation comorbidity index (HCT-CI), predicts mortality at a Canadian transplant center. Bone Marrow Transplant 43 (2009) 133-139
13. Xhaard A., Porcher R., Chien J.W., et al. Impact of comorbidity indexes on non-relapse mortality. Leukemia 22 (2008) 2062-2069
14. Piñana J.L., Martino R., Barba P., et al. Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-center experience. Bone Marrow Transplant (2009) [Epub ahead of print]
15. Klein J.P., Rizzo J.D., Zhang M.J., and Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant 28 (2001) 909-915
16. Klein J.P., Rizzo J.D., Zhang M.J., and Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: regression modeling. Bone Marrow Transplant 28 (2001) 1001-1011
17. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
18. Tarone R., and Ware J. On distribution-free test for equality of survival distributions. Biometrika 64 (1977) 156-160
19. Harrell Jr. F.E., Lee K.L., Califf R.M., Pryor D.B., and Rosati R.A. Regression modelling strategies for improved prognostic prediction. Stat Med 3 (1984) 143-152
20. Chien J.W., and Sullivan K.M. Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility?. Biol Blood Marrow Transplant 15 (2009) 447-453
21. Sorror M.L., Storer B., and Storb R.F. Validation of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in single and multiple institutions: limitations and inferences. Biol Blood Marrow Transplant 15 (2009) 757-758